Skip to content

Clinical Trials · Real-World Evidence · Publications

We run your trials. Then we turn the data into evidence.

End-to-end clinical trials from Phase I to IV, plus the real-world evidence, analytics and publications that follow. One partner, one data trail.

  • Great Place to Work® Certified, India, April 2026 to April 2027
  • Frost & Sullivan 2026 Best Practices Recognition: Indian Contract Research Organization Transformational Innovation Leadership

Our N is measured in decades, sites and studies.

  • 28+

    Years of experience

  • 500+

    Sites

  • 250+

    Clinical studies

  • 18+

    Therapeutic areas

  • 100+

    Audits successfully completed

From first patient to published finding.

Most CROs stop at database lock. We keep going.

Clinical Trials

  1. Run the trial

    Phase I–IV execution, designed for endpoints worth publishing.

  2. Extend after approval

    Post-marketing surveillance, outcomes studies and post-approval data.

Evidence

  1. Build real-world evidence

    SIRO-owned disease registries, built for Indian populations and practice.

  2. Mine and publish

    CSR mining, patient voice and KOL signals, powered by SIROai and turned into published evidence.

Our approach

Two disciplines, one method.

Good evidence starts with a well-run trial. A well-run trial is worth more when its data keeps working.

How We Run Trials

  • Designed for the endpoint that matters

    Protocol, sample size and endpoints are set with the eventual publication in view, not bolted on after database lock.

  • Inspection-ready from day one

    Rigorous oversight from site start-up to close-out, backed by 100+ audits successfully completed.

  • Reach across India

    500+ sites and 18+ therapeutic areas, so recruitment reflects the patients physicians actually treat.

How We Build Evidence

  • Evidence hiding in plain sight

    Subgroups, secondary endpoints, PROs and unextracted CSR findings, turned into peer-reviewed publications.

  • The molecule outlives the patent

    Post-approval, real-world and registry evidence keeps a molecule clinically relevant long after launch.

  • Closing the India evidence gap

    Global molecules are studied in Western populations. We generate the India-specific evidence global data cannot replace.

Everything a trial needs. Everything the evidence needs.

Trial Delivery

  • Clinical Operations

    Site selection to close-out, inspection-ready.

  • Data Management

    Audit-ready data from first patient in to database lock.

  • Biostatistics

    From protocol design and sample size to analysis.

  • Statistical Programming

    CDISC-compliant, submission-ready outputs.

  • Medical Services

    Medical monitoring, safety review and oversight.

  • Clinical Trial Supplies

    IP sourcing, packaging, labelling and distribution.

Evidence and Publication

  • Post-Approval Programs

    PMS, outcomes studies and real-world data collection.

  • Real-World Evidence

    Longitudinal disease registries across investigator sites.

  • Evidence Intelligence

    CSR mining, patient voice intelligence and KOL signal detection.

  • Medical Writing and Publications

    Protocols and CSRs to peer-reviewed papers, backed by one of Asia’s largest writing teams.

Why sponsors choose us

  • India’s first CRO

    28+ years of running trials across every major therapeutic area.

  • One data trail

    The team that runs your trial builds its evidence. No hand-offs, no data lost between vendors.

  • AI, validated by humans

    SIROai adds analytical depth, and every output is checked against human expert judgement.

Certified & rated

  • GDPR compliant
  • SBTi validated
  • EcoVadis rated
  • Great Place to Work® certified

The analytical depth of SIROai.The clinical reach of SIRO Clintech.

One evidence partner.

Explore SIROai